Document Detail


Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.
MedLine Citation:
PMID:  22240495     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AimsWe sought to investigate the impact of multivessel disease (MVD) with and without a chronic total occlusion (CTO) in a non-infarct-related artery (IRA) on mortality in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Methods and resultsIn the HORIZONS-AMI trial, of 3283 patients undergoing primary PCI, 1524 patients (46.4%) had single-vessel disease (SVD), 1477 (45.0%) had MVD without a CTO, and 283 (8.6%) had MVD with a CTO in a non-IRA. Compared with SVD patients and MVD patients without a CTO, patients with a non-IRA CTO were significantly less likely to achieve post-procedural TIMI 3 flow (P = 0.0003), more often had absent myocardial blush (P = 0.0002), and less frequently achieved complete ST-segment resolution (P = 0.0001). By multivariable analysis, MVD with CTO in a non-IRA was an independent predictor of both 0- to 30-day mortality [hazard ratio (HR) 2.88, 95% confidence interval (CI) 1.41-5.88, P = 0.004] and 30-day to 3-year mortality (HR 1.98, 95% CI 1.19-3.29, P= 0.009), while MVD without a CTO was a significant predictor for 0- to 30-day mortality (HR 2.20, 95% CI 1.00-3.06, P = 0.049) but not late mortality.ConclusionIn patients with STEMI undergoing primary PCI in the HORIZONS-AMI trial, MVD with or without a CTO in a non-IRA was an independent predictor of early mortality. The presence of a CTO in a non-IRA was also an independent predictor of increased late mortality to 3 years.
Authors:
Bimmer E Claessen; George D Dangas; Giora Weisz; Bernhard Witzenbichler; Giulio Guagliumi; Martin Möckel; Sorin J Brener; Ke Xu; José P S Henriques; Roxana Mehran; Gregg W Stone
Related Documents :
17711535 - Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after...
18590935 - Understanding peripartum cardiomyopathy, 2008.
22281245 - Silent ischemia clinical relevance.
12968195 - Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
17711535 - Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after...
12238835 - An ovine model of postinfarction dilated cardiomyopathy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-12
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cardiovascular Research Foundation, New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
Next Document:  Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a dou...